IGF-2 LR3Check methods and identity
What the IGF-2 LR3 Label Can Reliably Tell Us
2 numbered sourcesSource years 1992, 2026
Peptides are short chains of amino acids joined by peptide bonds. Longer amino-acid chains can fold into proteins that carry signals, including the insulin-like growth factors. The name IGF-2 LR3 does not identify a confirmed sequence in the supplied catalog. It combines wording associated with two distinct research subjects: human IGF-II and Long R3 IGF-I. Both are useful to study. Neither can be assigned to an unidentified material by similarity of name. [1, 2]
The older original study of Long R3 IGF-I by Francis and colleagues described a defined analog based on IGF-I. The investigators compared the activity of defined analogs with the original growth factor and examined how binding proteins affected their behavior. The paper identifies the starting growth factor as IGF-I. It does not describe an IGF-II product under the name IGF-2 LR3. [1]
A 2026 structural paper treated IGF-I and IGF-II as separate molecules. Zhang and colleagues compared how each engaged the insulin receptor and reported some similarities and some differences in the resulting structures. The study illustrates why a shared family name does not make two growth factors interchangeable. It studied known molecules and did not include an IGF-2 LR3 preparation. [2]
For a scientist, the useful starting information would be a supplier's verified molecular identity and evidence tying that identity to the material tested. A study that names an exact analog can support claims about that analog under its own conditions. An ambiguous label cannot tell a reader which of the two bodies of research to apply. Until the identity is established, claims about receptor activity, safety or effects of the catalog material are unresolved. [1, 2]
Sources
Original works cited in this article. Links open the external record in a new tab.
- 1.Francis GL et al. Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency. Journal of Molecular Endocrinology (1992-06). (opens in a new tab)
pubmed.ncbi.nlm.nih.gov↩ Back to text
